Definitive Contract W911SR21C0010

Award Date 2/16/21
Potential Completion Date 7/18/23
Potential Value $1M
Contracting Federal Agency
ACC Aberdeen Proving Ground
Ultimate Awardee
Not listed
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02138, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
STTR Phase II
Primary Consortia Member
Not listed
Similar Awards
This is a $1,099,504.56 firm-fixed-price contract awarded by the Joint PEO Chemical and Biological Defense, a part of the U.S. Army, to Clear Scientific, LLC, a small business. The contract is for a Phase II SBIR (Small Business Innovation Research) effort, with an ultimate completion date of August 4, 2025. Clear Scientific, LLC is a small business that provides research, development, manufacturing, and analytical services to U.S. federal agencies, primarily in support of pharmaceutical,...
This is a STTR Phase I contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Clear Scientific, LLC, a small business, for $149,994.35. The contract supports nanotechnology research and development under proposal number A18B-024-0208. As a Small Business Innovation Research (SBIR) contract, it is set-aside for small businesses. Based on Clear Scientific's background, the research is likely focused on developing new pharmaceutical, medical, or...
This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Clear Scientific, LLC, a small business limited liability company. The contract, valued at $167,474.81, is for research and development services in support of pharmaceutical, medical, and defense programs. Clear Scientific has previously received prime contract awards and subcontracts from the Department of Defense and...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Clear Scientific, LLC, a for-profit limited liability company. The $999,613.38 Firm Fixed Price contract supports research and development of drug formulations, quality control, and analytical testing services primarily for pharmaceutical, medical, and defense programs. Clear Scientific has prior experience providing...
This is a $167,481.06 firm fixed price purchase order awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Clear Scientific, LLC, a small business limited liability company, for an ARMY SBIR PHASE I contract. The contract is set-aside for small businesses. Clear Scientific, LLC provides research, development, manufacturing, and analytical services to U.S. federal agencies, primarily in support of pharmaceutical, medical, and defense...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Clear Scientific, LLC, a for-profit limited liability company. The $167,420.88 firm fixed-price contract is for the development of colorometric detection inks that can be printed using off-the-shelf inkjet cartridges to detect hazardous compounds. This research supports the agency's chemical and biological defense programs. As...
This is a $999,999.96 Firm Fixed Price definitive contract awarded to Rdmchem LLC, a for-profit limited liability company, by the U.S. Army Research, Development and Engineering Command (RDECOM). The contract was set aside for a small business under the Small Business Technology Transfer (STTR) program and is for the second monthly technical report in the STTR Phase II research effort. The contract has an ultimate completion date of October 25, 2018, with an award date of November 3, 2015.
This $1.5 million firm fixed price contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Clear Scientific, LLC for an Army Small Business Innovation Research (SBIR) Phase II project. As a total small business set aside, the two year contract runs from January 2020 through September 2022 and calls for Clear Scientific to perform further research and development of technologies initially explored during SBIR Phase I under this...
This federal contract award was made by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Clear Scientific, LLC, a small business limited liability company, under the Small Business Innovation Research (SBIR) Program Phase I. The $149,972.66 firm fixed-price purchase order is for research and development services in support of chemical and biological defense programs. As a prime contractor, Clear Scientific has previously provided drug...
This is a $111,229.44 firm-fixed-price purchase order awarded by the Defense Health Agency to Clear Scientific, LLC, a for-profit limited liability company. The contract is for drug formulation, quality assurance/quality control, method development, and sample analysis services to support pharmaceutical, medical, and defense programs. Clear Scientific has previously provided similar services as a prime contractor and subcontractor to the Department of Defense and Department of the Army. The...

This is a $999,959.91 Firm Fixed Price contract awarded to Clear Scientific, LLC, a small business, by the U.S. Army's Research, Development and Engineering Command (RDECOM) for the SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PHASE II development of PAPER SPRAY MASS SPECTROMETRY CARTRIDGES WITH INTEGRATED SAMPLING AND ENRICHMENT. The contract has a completion date of July 18, 2023. Clear Scientific has previously provided drug formulation, quality control, analytical testing, and technical reporting services to the Department of Defense and Department of the Army. This STTR Phase II award supports the company's ongoing research and development efforts focused on obtaining FDA approval for therapeutic agents to treat opioid and methamphetamine intoxication and overdose.

Generated 1/4/25, 9:04 AM